 |
 |
Search
- Page Path
-
- HOME
- Search
- IBD
- Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study
- Avnish Kumar Seth, Priti Jain
- Intest Res. 2022;20(2):251-259. Published online February 8, 2022
- Full text PubReader ePub PDF
- Landscape of inflammatory bowel disease in Singapore
- Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi
- Intest Res. 2022;20(3):291-296. Published online January 7, 2022
- Full text PubReader ePub PDF
|
|
- Artificial intelligence for endoscopy in inflammatory bowel disease
- Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka
- Intest Res. 2022;20(2):165-170. Published online January 7, 2022
- Full text PubReader ePub PDF
|
|
- Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
- Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki
- Intest Res. 2022;20(3):329-341. Published online August 4, 2021
- Full text PubReader ePub PDF Supplementary Material
|
|
- Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease
- Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, Hyun Mi Lee, Won Eui Yoon, Seo Hyun Kim, Hee Jun Myung, Jeong Seop Moon
- Intest Res. 2022;20(3):321-328. Published online July 20, 2021
- Full text PubReader ePub PDF
|
|
- Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
- Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, Kirandeep Kaur, Vandana Midha, Pabitra Sahu, Varun Mehta, Dharmatma Singh, Namita Bansal, Khushdeep Dharni, Sandeep Kaushal, Vineet Ahuja, Ajit Sood
- Intest Res. 2022;20(1):64-71. Published online February 3, 2021
- Full text PubReader ePub PDF
|
|
- Inflammatory Bowel Diseases
- Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy
- Ryohei Hayashi, Yoshitaka Ueno, Shinji Tanaka, Kana Onishi, Takeshi Takasago, Masaki Wakai, Toshikatsu Naito, Kensuke Sasaki, Shigehiro Doi, Takao Masaki, Kazuaki Chayama
- Intest Res. 2021;19(4):430-437. Published online November 9, 2020
- Full text PubReader ePub PDF
|
|
- IBD
- Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment
- Shintaro Akiyama, Victoria Rai, David T. Rubin
- Intest Res. 2021;19(1):1-11. Published online November 5, 2020
- Full text PubReader ePub PDF
|
|
- Inflammatory Bowel Diseases
- Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
- Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul
- Intest Res. 2021;19(1):71-82. Published online September 4, 2020
- Full text PubReader ePub PDF Supplementary Material
|
|
- Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
- Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Evangelia Legaki, Maria Gazouli, Ioannis E. Koutroubakis
- Intest Res. 2021;19(4):461-467. Published online August 18, 2020
- Full text PubReader ePub PDF
|
|
- Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
- Shin Ju Oh, Ga Young Shin, Hosim Soh, Jae Gon Lee, Jong Pil Im, Chang Soo Eun, Kang-Moon Lee, Dong Il Park, Dong Soo Han, Hyo Jong Kim, Chang Kyun Lee
- Intest Res. 2021;19(3):323-331. Published online August 18, 2020
- Full text PubReader ePub PDF
|
|
- Temporal trend in the natural history of ulcerative colitis in a country with a low incidence of ulcerative colitis from 2000 through 2018
- Satimai Aniwan, Julajak Limsrivilai, Supot Pongprasobchai, Nonthalee Pausawasdi, Piyapan Prueksapanich, Natanong Kongtub, Rungsun Rerknimitr
- Intest Res. 2021;19(2):186-193. Published online August 18, 2020
- Full text PubReader ePub PDF
|
|
- Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
- Ajit Sood, Kirandeep Kaur, Ramit Mahajan, Vandana Midha, Arshdeep Singh, Sarit Sharma, Amarender Singh Puri, Bhabhadev Goswami, Devendra Desai, C. Ganesh Pai, Kiran Peddi, Mathew Philip, Rakesh Kochhar, Sandeep Nijhawan, Shobna Bhatia, N. Sridhara Rao
- Intest Res. 2021;19(2):206-216. Published online July 13, 2020
- Full text PubReader ePub PDF
|
|
- Inflammatory bowel diseases
- Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
- Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kirandeep Kaur, Rajeev Khosla, Ajay Kumar, Ramit Mahajan, S. P. Misra, Kiran Peddi, Shivaram Prasad Singh, Arshdeep Singh
- Intest Res. 2020;18(4):355-378. Published online July 13, 2020
- Full text PubReader ePub PDF
|
|
- Inflammatory Bowel Diseases
- Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
- Hiroyuki Okamoto, Nathanael L. Dirks, Maria Rosario, Tetsuharu Hori, Toshifumi Hibi
- Intest Res. 2021;19(1):95-105. Published online July 10, 2020
- Full text PubReader ePub PDF Supplementary Material
|
|
- Editorial Office
-
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org
Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.
